Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
17.34
+0.01 (0.06%)
At close: Apr 17, 2026, 4:00 PM EDT
17.65
+0.31 (1.79%)
After-hours: Apr 17, 2026, 7:23 PM EDT

Pharming Group Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
1,2451,240685767724580
Market Cap Growth
135.29%80.98%-10.69%5.95%24.82%-40.25%
Enterprise Value
1,1811,168622.3719.72678.07545.52
Last Close Price
17.3417.6710.0711.4311.038.94
PE Ratio
436.60441.75-55.94-71.4458.0538.87
PS Ratio
3.313.302.313.133.522.92
PB Ratio
4.494.473.103.513.543.01
P/TBV Ratio
4.604.763.583.793.813.25
P/FCF Ratio
23.0722.98-265.02-40.9334.3421.40
P/OCF Ratio
22.7522.66-381.65-44.3332.2415.33
EV/Sales Ratio
3.143.102.092.933.302.74
EV/EBITDA Ratio
29.8138.25118.04-56.1821.5816.45
EV/EBIT Ratio
36.0660.47-57.63-25.0537.1940.23
EV/FCF Ratio
21.8921.64-240.73-38.4132.1620.13
Debt / Equity Ratio
0.390.390.480.760.790.82
Debt / EBITDA Ratio
3.133.7921.30-13.395.314.88
Debt / FCF Ratio
2.152.15-43.45-9.157.915.97
Net Debt / Equity Ratio
-0.23-0.23-0.25-0.19-0.20-0.16
Net Debt / EBITDA Ratio
-1.71-2.07-10.543.27-1.29-0.91
Net Debt / FCF Ratio
-1.17-1.1721.502.24-1.93-1.11
Asset Turnover
0.840.840.690.550.500.49
Inventory Turnover
0.750.750.630.510.500.87
Quick Ratio
2.022.023.023.333.944.74
Current Ratio
2.592.593.774.064.655.33
Return on Equity (ROE)
1.01%1.60%-7.12%-16.26%6.88%8.50%
Return on Assets (ROA)
10.55%4.29%-2.50%-6.47%4.82%3.32%
Return on Invested Capital (ROIC)
24.95%10.15%-6.31%-16.86%12.13%8.26%
Return on Capital Employed (ROCE)
7.25%5.44%-3.04%-7.65%5.09%3.92%
Earnings Yield
0.23%0.23%-1.79%-1.40%1.72%2.57%
FCF Yield
4.33%4.35%-0.38%-2.44%2.91%4.67%
Buyback Yield / Dilution
-11.25%4.91%-8.26%-2.59%-0.85%-2.70%
Total Shareholder Return
-11.25%4.91%-8.26%-2.59%-0.85%-2.70%
Updated Mar 12, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q